Position in ONC
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,973,856
-$1,811,758 QoQ
Shares Held
10,014
-36.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in ONC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,973,856 | 10,014 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,785,614 | 15,752 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $9,327,343 | 27,377 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $31,600,024 | 116,104 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $22,829,232 | 123,595 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $28,156,247 | 125,412 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $16,318,308 | 114,378 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $17,637,507 | 112,779 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,335,937 | 101,663 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $18,033,046 | 100,256 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $9,314,034 | 52,238 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $7,475,226 | 34,683 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $3,944,623 | 17,935 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $2,289,378 | 16,981 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $2,965,092 | 18,320 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $4,519,798 | 23,965 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $6,644,828 | 24,526 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $8,869,179 | 24,433 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $8,351,871 | 24,336 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $10,217,191 | 29,353 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,310,369 | 28,292 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,078,390 | 35,185 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,021,048 | 26,651 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,960,918 | 24,051 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||